IMU 0.00% 4.8¢ imugene limited

more info and exposure, page-3

  1. 1,460 Posts.
    lightbulb Created with Sketch. 275
    This company has released nothing but positive announcements for the last 12 months and the SP isn't close to reflecting it's true value.

    Financial institutions have modestly valued this company above 3 cents based on their patents, science and market opportunity.

    Clinical trials are so close to kicking off in HK, information regarding a mimotope vaccine is also soon to be released.

    Early positive results with HER-Vaxx could lead to a big deal and add multiples to the market cap. There's no way the SP can hold at this level when the company is moving full steam ahead.

    The penny will drop when risk is lowered and HIGH opportunity is revealed. This company is currently a bargain under 3 cents.

    It's not until it moves everyone will come to realise.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.